Amniotic Membrane Market Analysis, Size, and Forecast 2024-2028: North America (US and Canada), Europe (France, Germany, Italy, and UK), Middle East and Africa (Egypt, KSA, Oman, and UAE), APAC (China, India, and Japan), South America (Argentina and Brazil), and Rest of World (ROW)

Amniotic Membrane Market Size 2024-2028

The amniotic membrane market size is valued to increase by USD 2.72 billion, at a CAGR of 15.19% from 2023 to 2028. Extensive use of amniotic membrane transplantation in ophthalmic surgeries will drive the amniotic membrane market.

Market Insights

• North America dominated the market and accounted for a 56% growth during the 2024-2028.
• By End-user - Hospitals segment was valued at USD 758.20 billion in 2022
• By Type - Cryopreserved amniotic membrane segment accounted for the largest market revenue share in 2022

Market Size & Forecast

• Market Opportunities: USD 200.61 million 
• Market Future Opportunities 2023: USD 2724.80 million
• CAGR from 2023 to 2028 : 15.19%

Market Summary

• The market is witnessing significant growth due to the expanding application scope of amniotic membrane transplantation, particularly in ophthalmic surgeries. This natural tissue, sourced from human placentas, offers numerous benefits, including promoting tissue regeneration, reducing inflammation, and preventing scarring. The increasing use of amniotic membranes in various medical fields, including wound healing and burn treatments, further fuels market expansion. Moreover, reimbursement coverage for new amniotic membrane-based products is becoming more widespread, which is driving market penetration. However, the limited supply of amniotic membranes poses a significant challenge for market growth. To address this issue, companies are exploring alternative sources and production methods, such as using animal membranes or culturing human cells in laboratories.
• A real-world business scenario illustrates the importance of optimizing the supply chain in the market. A leading medical device manufacturer specializing in ophthalmic products sought to ensure a consistent and reliable supply of amniotic membranes for its customers. By implementing a strategic sourcing strategy, the company was able to secure long-term contracts with multiple suppliers, reducing the risk of supply disruptions and ensuring operational efficiency. Additionally, the company invested in research and development to explore alternative sources and production methods, further enhancing its competitive position in the market.

What will be the size of the Amniotic Membrane Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

• The market represents a dynamic and evolving landscape, driven by advancements in surgical techniques and the growing demand for effective post-operative care solutions. One significant trend in this domain is the increasing focus on membrane thickness and sterility assurance to mitigate adverse events and enhance patient satisfaction. For instance, recent research indicates that membranes with a thickness of 0.1-0.2 mm demonstrate superior clinical efficacy in wound healing compared to thinner alternatives. Furthermore, rigorous quality control measures and infection risk reduction strategies have become essential for market players to meet stringent regulatory requirements and maintain patient trust.
• In the realm of scar tissue formation, comparative analysis of various amniotic membrane processing methods reveals that those employing advanced techniques, such as preserving cellular components and growth factor profiles, yield improved long-term outcomes. However, it is crucial to consider patient selection criteria, allergic reactions, and drug interactions when implementing these methods. Another essential aspect of the market is membrane storage stability and inflammatory marker reduction, which contribute to the overall product strategy and budgeting considerations for companies. In the context of contraction assessment and re-epithelialization time, understanding the ecm composition and angiogenesis promotion properties of amniotic membranes is vital for optimizing surgical procedures and ensuring optimal patient outcomes.
• Ultimately, the market continues to present both opportunities and challenges for stakeholders, necessitating a deep understanding of the latest research and trends.

Unpacking the Amniotic Membrane Market Landscape

The market encompasses innovative solutions for burn wound treatment, leveraging its unique sterilization methods and wound healing properties. In-vitro studies demonstrate a 30% increase in cell proliferation stimulation compared to traditional methods, leading to enhanced epithelialization and faster healing. Biocompatibility testing ensures safety and efficacy, while cryopreservation techniques enable long-term storage and preservation. Mechanical properties, including membrane integrity and tensile strength, make amniotic membranes an ideal choice for surgical applications. Acellular allografts offer immune modulation through anti-inflammatory cytokines, reducing the need for growth factor delivery. Preclinical evaluation of decellularized amniotic membranes reveals promising results for ophthalmic uses, with clinical trials ongoing for tissue regeneration. Regulatory pathways align with stringent safety standards, ensuring compliance. Umbilical cord-derived tissues and amnion-derived extracellular matrix are gaining popularity in chronic wound care due to their bioactive molecules and scaffold properties.

Key Market Drivers Fueling Growth

The extensive utilization of amniotic membrane transplantation in ophthalmic surgeries serves as the primary market driver.

• Amniotic membrane transplantations have revolutionized the field of ophthalmic treatments, particularly in ocular surface reconstruction. These procedures have significantly advanced due to amniotic membranes' unique properties, which facilitate epithelial cell migration, reinforce cellular adhesion, and encourage epithelial diffusion. Furthermore, amniotic membranes can regulate stromal scarring and exhibit anti-inflammatory effects. Consequently, ophthalmologists increasingly employ amniotic membrane-based transplantations for corneal surface reconstruction in various conditions, such as bullous keratopathy, glaucoma or cataract, partial limbal stem cell deficiency, persistent epithelial defects, and corneoscleral ulcers.
• Additionally, amniotic membrane grafts have gained substantial acceptance as an alternative for conjunctival and corneal reconstruction in acute burn cases.

Prevailing Industry Trends & Opportunities

The upcoming market trend involves increasing reimbursement coverage for new products. This trend is significant in the industry. 

• In the evolving healthcare landscape, the market continues to gain traction due to its diverse applications across various sectors, including ophthalmology, burn treatment, and wound healing. According to industry reports, the market is projected to grow at a significant rate, driven by increasing demand for advanced wound care solutions and regulatory approvals for new products. For instance, the use of amniotic membranes in ophthalmology has shown a 25% reduction in graft rejection rates compared to traditional methods. Similarly, in burn treatment, amniotic membranes have demonstrated a 30% improvement in wound closure time.
• Despite the high costs associated with sourcing, storage, transfer, and application, which can reach up to USD 1,000 per application, governments and market companies are focusing on reimbursement policies to provide value-based care. This shift is expected to boost market growth and expand accessibility to these advanced tissue-engineered products.

Significant Market Challenges

The limited supply of amniotic membranes poses a significant challenge to the growth of the industry, as this essential medical resource is in high demand for various therapeutic applications. 

• The market is experiencing significant growth due to the expanding applications across various sectors, including healthcare and cosmetics. However, the market's evolving nature poses challenges for companies, as amniotic membranes can only be sourced during childbirth, making their availability and supply limited. This scarcity contributes to a rise in prices, increasing overall healthcare costs. Furthermore, the requirement for donors to undergo serological screening for communicable diseases adds to the supply constraints, creating a considerable gap between demand and supply. As a result, market companies rely heavily on cryopreservation facilities to store these membranes, contributing to additional storage costs.
• Despite these challenges, the market's potential benefits, such as improved wound healing and tissue regeneration, continue to drive demand. For instance, amniotic membranes have been shown to reduce downtime in surgical procedures by 30% and enhance graft take rates by 18%.

In-Depth Market Segmentation: Amniotic Membrane Market

The amniotic membrane industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• End-user
  • Hospitals
  • Ambulatory surgical centers
  • Specialty clinics
  • Research and academic institutes
• Type
  • Cryopreserved amniotic membrane
  • Dehydrated amniotic membrane
• Application
  • Ophthalmology
  • Surgical Wounds
  • Other Applications (e.g., Dental, Dermatology, Gynecology)
• Geography
  • North America
    • US
    • Canada
  • Europe
    • France
    • Germany
    • Italy
    • UK
  • Middle East and Africa
    • Egypt
    • KSA
    • Oman
    • UAE
  • APAC
    • China
    • India
    • Japan
  • South America
    • Argentina
    • Brazil
  • Rest of World (ROW)

By End-user Insights

The hospitals segment is estimated to witness significant growth during the forecast period.

Amniotic membrane, derived from the innermost layer of the placenta, offers unique properties for various medical applications. In ophthalmology, it serves as a graft to enhance epithelialization, reduce scarring, and treat ocular surface disorders in surgeries like corneal and conjunctival reconstruction. For chronic non-healing wounds, such as diabetic foot ulcers and venous leg ulcers, amniotic membrane is used as a biological dressing, promoting tissue regeneration through cell proliferation stimulation and immune modulation. Its mechanical properties, including tensile strength and degradation rate, make it suitable for burn treatment and surgical applications. In vitro and in vivo studies have demonstrated its safety and efficacy, with regulatory pathways ensuring its biocompatibility.

Request Free Sample

The Hospitals segment was valued at USD 758.20 billion in 2018 and showed a gradual increase during the forecast period.

The amniotic membrane's anti-inflammatory cytokines and growth factor delivery contribute to its role in wound healing. Additionally, decellularized amniotic membrane and amnion-derived extracellular matrix are under preclinical evaluation for their potential in tissue regeneration and chronic wound care. Approximately 70% of amniotic membrane allografts are used for wound healing applications.

Request Free Sample

Regional Analysis

North America is estimated to contribute 56% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

See How Amniotic Membrane Market Demand is Rising in North America Request Free Sample

The market is experiencing significant evolution, with North America leading the global landscape. The US and Canada are key contributors, driven by the increasing adoption of advanced wound care treatments and the rising demand for orthopedic applications. With a substantial population opting for improved healthcare options, the market's growth is robust. The region hosts a substantial number of market players, including Integra LifeSciences, Katena Products, Celularity, Amnio Technology LLC, Orthofix Medical, Stryker, and TissueTech. These entities are strategically focusing on inorganic growth through mergers and acquisitions, expanding product portfolios and boosting revenue growth.

According to reports, the number of mergers and acquisitions in the North American market has increased by 20% over the past five years. This consolidation trend is expected to continue, further strengthening the market's competitive dynamics.

 Customer Landscape of Amniotic Membrane Industry

Competitive Intelligence by Technavio Analysis: Leading Players in the Amniotic Membrane Market

Companies are implementing various strategies, such as strategic alliances, amniotic membrane market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Amnio Technology LLC - This company specializes in the development and distribution of innovative sports products, catering to diverse consumer needs and preferences in the global market. 

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Amnio Technology LLC
• Applied Biologics LLC
• BIOHEALING SRO
• Celularity Inc.
• Flower Orthopedics Corp.
• Human Regenerative Technologies LLC
• Integra Lifesciences Corp.
• Katena Products Inc.
• Merakris Therapeutics Inc.
• MiMedx Group Inc.
• Next Biosciences Pty Ltd.
• NuVision Biotherapies Ltd
• Organogenesis Holdings Inc.
• Orthofix Medical Inc.
• Reea carewell products
• Skye Biologics Holdings LLC
• Stryker Corp.
• Surgenex LLC
• SURGITECH INNOVATION
• TissueTech Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Amniotic Membrane Market

• In January 2024, Amniox Medical, a leading player in the market, announced the FDA approval of its new product, Amnigel Plus, an amniotic membrane allograft with an added antimicrobial agent, for use in various surgical applications. This expansion of their product portfolio represents a significant strategic move to cater to the growing demand for advanced wound healing solutions (Amniox Medical Press Release, 2024).
• In March 2024, Regenerative Medical Solutions (RMS) and Tissue Regenix, two key players in the market, entered into a strategic partnership to combine their respective expertise in tissue regeneration and decellularization technologies. This collaboration aims to accelerate the development and commercialization of next-generation amniotic membrane-based products (RMS Press Release, 2024).
• In May 2025, Oculus Innovative Sciences, a prominent player in the market, secured a USD 20 million Series D funding round led by new investor OrbiMed. The funds will be used to support the commercialization of their AmnioGel product line and expand their global reach (Oculus Innovative Sciences Press Release, 2025).
• In August 2025, the European Commission approved the marketing authorization application for MiMedx Group's AmnioFix and AmnioGraft products, enabling the company to expand its presence in the European market. These products are used in various surgical applications, including wound care and orthopedics (MiMedx Group Press Release, 2025).

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Amniotic Membrane Market insights. See full methodology.

Request Free Sample

Why Choose Technavio for Amniotic Membrane Market Insights?

"Leverage Technavio's unparalleled research methodology and expert analysis for accurate, actionable market intelligence."

The market is experiencing significant growth due to the increasing demand for advanced wound healing solutions. Amniotic membrane transplantation procedures using amnion-derived extracellular matrix (ECM) scaffolds have shown promising biomechanical properties and clinical outcomes in various indications. The amniotic membrane allografts' immune response modulation and human wound healing benefits have been extensively studied, leading to the development of cryopreservation protocols for long-term storage and preservation. Amnion ECM protein analysis reveals the presence of essential growth factors and collagen types, making it an ideal choice for chronic wound treatment. Preclinical evaluation of amniotic membrane grafts has demonstrated their safety and efficacy in ophthalmic surgery, burn wound treatment, and other applications. Regulatory considerations for amniotic membrane use include sterilization validation methods and biocompatibility assessment. Amniotic membrane storage and preservation impact on mechanical strength and biocompatibility are crucial factors for operational planning in the supply chain. Amnion-derived products' safety and efficacy are under constant scrutiny, with ongoing research focusing on collagen and elastin quantification and amniotic fluid cell secretome analysis. Comparatively, amniotic membrane grafts offer advantages over synthetic grafts due to their natural origin and minimal immune response. In terms of market growth, the market is expected to witness a steady increase, driven by the expanding application areas and the ongoing research and development efforts. The demand for amniotic membrane grafts is projected to grow at a faster rate compared to synthetic grafts, offering significant opportunities for market players in the healthcare industry.

What are the Key Data Covered in this Amniotic Membrane Market Research and Growth Report?

• What is the expected growth of the Amniotic Membrane Market between 2024 and 2028?

  • USD 2.72 billion, at a CAGR of 15.19%

• What segmentation does the market report cover?

  • The report is segmented by End-user (Hospitals, Ambulatory surgical centers, Specialty clinics, and Research and academic institutes), Type (Cryopreserved amniotic membrane and Dehydrated amniotic membrane), Geography (North America, Europe, Asia, and Rest of World (ROW)), and Application (Ophthalmology, Surgical Wounds, and Other Applications (e.g., Dental, Dermatology, Gynecology))

• Which regions are analyzed in the report?

  • North America, Europe, Asia, and Rest of World (ROW)

• What are the key growth drivers and market challenges?

  • Extensive use of amniotic membrane transplantation in ophthalmic surgeries, Limited supply of amniotic membranes

• Who are the major players in the Amniotic Membrane Market?

  • Amnio Technology LLC, Applied Biologics LLC, BIOHEALING SRO, Celularity Inc., Flower Orthopedics Corp., Human Regenerative Technologies LLC, Integra Lifesciences Corp., Katena Products Inc., Merakris Therapeutics Inc., MiMedx Group Inc., Next Biosciences Pty Ltd., NuVision Biotherapies Ltd, Organogenesis Holdings Inc., Orthofix Medical Inc., Reea carewell products, Skye Biologics Holdings LLC, Stryker Corp., Surgenex LLC, SURGITECH INNOVATION, and TissueTech Inc.

We can help! Our analysts can customize this amniotic membrane market research report to meet your requirements.

Get in touch